Angela Waanders, MD, MPH

Clinical and Community Trials

Biography

  • Interim Head, Neuro-Oncology, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Director, Precision Medicine Oncology, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Executive Board Chair, Children's Brain Tumor Tissue Consortium, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Max Lacewell Endowed Brain Tumor Research Scholar, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Associate Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

  • Fellowship in Pediatric Hematology/Oncology, Children's Hospital of Philadelphia 2006-2009
  • Residency is Pediatrics, Children's Hospital of Philadelphia 2003-2006
  • MD, Tulane University School of Medicine 2003

Clinical Studies

Recruiting

Trametinib and Everolimus for the Treatment of Pediatric and Young Adult Patients With Recurrent Low Grade Gliomas (PNOC021)

Recruiting

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Recruiting

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors

Recruiting

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults

Publications

Feb. 14, 2021

Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).

Feb. 09, 2021

BRAF fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers.

Feb. 05, 2021

A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study.

See all publications

Similar Researchers

Clinical and Community Trials

Jeremy N. Wong, MD

Brian E. Nolan, MD

Recent Publication

Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients

Jul. 05, 2021
Clinical and Community Trials

Todd Florin, MD, MSCE

Research Interests

Pediatric Respiratory Infections, Pediatric Emergency Medicine, Clinical and Molecular Epidemiology, Antimicrobial Stewardship, Predictive Analytics

Recent Publication

A Prediction Model for Pediatric Radiographic Pneumonia

Dec. 01, 2021

Erin Bressler, MD

Kiona Y. Allen, MD

Recent Publication

Targeted Temperature Management Protocol in a Pediatric Intensive Care Unit: A Quality Improvement Project.

Oct. 01, 2021

Kendra M. Ward, MD, MSCI